Salix Pharmaceuticals, Ltd. Brings Colorectal Screening Outreach to Consumers in Partnership with Walgreens and the Colon Cancer Alliance
RALEIGH, N.C.--(BUSINESS WIRE)--As a result of measurable success last year, Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) is again partnering with Walgreens (NYSE, NASDAQ: WAG) and the Colon Cancer Alliance (CCA) to raise awareness and increase screenings for colorectal cancer during Colorectal Cancer Awareness Month.